Andrew Nunn

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial

Malcolm Kohler, John Stradling, Daniel J Bratton, 2012, Thorax.

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

Jeremy Hobart, John Zajicek, J. Hobart, 2013, The Lancet Neurology.

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

Sheena McCormack, Helen Rees, Heiner Grosskurth, 2010, The Lancet.

Determinants of Survival Without Antiretroviral Therapy After Infancy in HIV-1-Infected Zambian Children in the CHAP Trial

Veronica Mulenga, Chifumbe Chintu, Diana M. Gibb, 2006, Journal of acquired immune deficiency syndromes.

HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

Steve Kaye, Francoise Brun-Vezinet, Rob Schuurman, 1997, The Lancet.

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.

James Shearer, David J. Miller, Jeremy Hobart, 2015, Health technology assessment.